Table 4 Performance of our framework for NC vs. AD, subcortical vascular disease with no cognitive impairment (NCI) vs. subcortical vascular mild cognitive impairment (svMCI), and methylated MGMT (MGMT+) vs. unmethylated MGMT (MGMT-) classifications
Methods | AUC | ACC | Sensitivity | Specificity | F1-score |
|---|---|---|---|---|---|
NC vs. AD on OASIS-3 (pretrained on ADNI) | |||||
3D CNN (SI) | 0.852 ± 0.020 | 0.772 ± 0.014 | 0.710 ± 0.091 | 0.826 ± 0.103 | 0.743 ± 0.014 |
3D CNN (MI) | 0.885 ± 0.003 | 0.821 ± 0.007 | 0.719 ± 0.023 | 0.912 ± 0.013 | 0.790 ± 0.011 |
Ours3DCNN (SI+MmFE) | 0.890 ± 0.005 | 0.831 ± 0.004 | 0.752 ± 0.024 | 0.900 ± 0.018 | 0.806 ± 0.008 |
NC vs. AD on HS Hospital (pretrained on ADNI) | |||||
3D CNN (SI) | 0.751 ± 0.081 | 0.718 ± 0.038 | 0.639 ± 0.067 | 0.774 ± 0.043 | 0.639 ± 0.055 |
3D CNN (MI) | 0.863 ± 0.076 | 0.839 ± 0.043 | 0.754 ± 0.086 | 0.912 ± 0.043 | 0.778 ± 0.046 |
Ours3DCNN (SI+MmFE) | 0.849 ± 0.098 | 0.783 ± 0.078 | 0.734 ± 0.085 | 0.810 ± 0.106 | 0.730 ± 0.080 |
NCI vs. svMCI on RJ Hospital | |||||
3D CNN (SI) | 0.677 ± 0.036 | 0.649 ± 0.034 | 0.634 ± 0.079 | 0.676 ± 0.099 | 0.670 ± 0.057 |
3D CNN (MI) | 0.713 ± 0.041 | 0.676 ± 0.064 | 0.697 ± 0.066 | 0.680 ± 0.149 | 0.708 ± 0.066 |
Ours3DCNN (SI+MmFE) | 0.705 ± 0.040 | 0.660 ± 0.051 | 0.684 ± 0.105 | 0.662 ± 0.095 | 0.693 ± 0.057 |
MGMT+ vs. MGMT- on BraTS 2021 | |||||
3D CNN (SI) | 0.574 ± 0.036 | 0.564 ± 0.022 | 0.539 ± 0.035 | 0.591 ± 0.033 | 0.562 ± 0.025 |
3D CNN (MI) | 0.594 ± 0.030 | 0.581 ± 0.034 | 0.602 ± 0.057 | 0.556 ± 0.029 | 0.598 ± 0.052 |
Ours3DCNN (SI+MmFE) | 0.600 ± 0.023 | 0.593 ± 0.025 | 0.634 ± 0.060 | 0.544 ± 0.074 | 0.616 ± 0.048 |